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Selective degeneration of midbrain dopaminergic
(mDA) neurons is associated with Parkinson’s dis-
ease (PD), and thus an in-depth understanding of
molecular pathways underlying mDA development
will be crucial for optimal bioassays and cell replace-
ment therapy for PD. In this study, we identified a
novel Wnt1-Lmx1a autoregulatory loop during mDA
differentiation of ESCs and confirmed its in vivo pres-
ence during embryonic development. We found that
the Wnt1-Lmx1a autoregulatory loop directly regu-
lates Otx2 through the b-catenin complex and
Nurr1 and Pitx3 through Lmx1a. We also found that
Lmx1a and Lmx1b cooperatively regulate mDA
differentiation with overlapping and cross-regulatory
functions. Furthermore, coactivation of both Wnt1
and SHH pathways by exogenous expression of
Lmx1a, Otx2, and FoxA2 synergistically enhanced
the differentiation of ESCs to mDA neurons. Together
with previous works, this study shows that two regu-
latory loops (Wnt1-Lmx1a and SHH-FoxA2) critically
link extrinsic signals to cell-intrinsic factors and
cooperatively regulate mDA neuron development.
INTRODUCTION
During early brain development, mDA neurons originate from the
ventral midline of the mesencephalon. The initial event of mDA
neuron development was shown to depend on Sonic hedgehog
(SHH), fibroblast growth factor 8 (FGF8), and Wnt1, setting up
the initial field for mDA progenitors (McMahon and Bradley,
1990; Prakash et al., 2006; Ye et al., 1998). Among these,
Wnt1 and FGF8 are expressed from Isthmus and they cross-
regulate each other (Chi et al., 2003; Lee et al., 1997; Liu and
Joyner, 2001; Matsunaga et al., 2002). Recent studies showing
that FGF8 failed to induce ectopic DA neurons in Wnt1 mutant
embryos (Prakash et al., 2006) suggest that Wnt1, which can
be induced by FGF8, is a more direct regulator of initiation of
mDA fields. Furthermore, a recent study established that646 Cell Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Incompound FGFR mutant mice show that FGF8 regulates mDA
neuronal precursors (NP) proliferation rather than mDA identity,
the latter being more critically mediated by SHH andWnt1 (Saar-
imaki-Vire et al., 2007). SHH expressed from the notochord has
been shown to directly induce FoxA2 expression in ventral
mesencephalon (VM) through Gli binding sites in the FoxA2
gene (Sasaki et al., 1997). FoxA2, in turn, directly induces VM
SHH expression through well-conserved FoxA2 binding sites in
the SHH gene (Jeong and Epstein, 2003). FoxA2 regulates
mDA development by inhibiting an alternate fate (Nkx2.2+ cells),
inducing neurogenesis through Ngn2, and regulating Nurr1 and
DA phenotype genes (Ferri et al., 2007) as well as regulating
survival/maintenance of mDA neurons (Arenas, 2008; Kittappa
et al., 2007), strongly suggesting that FoxA2 is themainmediator
of SHH signaling inmDA development. Taken together, SHH and
Wnt1 are two major extrinsic signals that play critical roles in
mDA development. However, for Wnt1, it is less clear what are
its direct downstream target genes. These extrinsic signals are
thought to initiate the regulatory cascades leading tomDA devel-
opment by inducing key transcription factors. Indeed, down-
stream from these initial signaling molecules, numerous tran-
scription factors have been implicated, including FoxA2, Otx2,
Lmx1a, Lmx1b, Nurr1, and Pitx3 (Ang, 2006; Smidt and Burbach,
2007). How these extrinsic signals and intrinsic transcription
factors interact with each other is of utmost importance not
only for our understanding of the regulatory network of mDA
development but also for optimal stem cell engineering for cell
replacement therapy of PD.
Recently, an important transcriptional pathway involving the
homeodomain protein Lmx1a has been identified; Lmx1a is
expressed in early DA progenitors and induces another homeo-
domain factor, Msx1, which then suppresses alternative cell
fates by suppressing the Nkx6.1 gene and induces neurogenesis
by activating the proneural gene, Ngn2 (Andersson et al., 2006b).
This study showed that Lmx1a is important for mDA develop-
ment by gain- and loss-of-function analyses in chick embryos.
Interestingly, dreher mutant mice carrying a mutation in the
Lmx1a locus (Millonig et al., 2000) showed only modest develop-
mental defect of mDA neurons (Ono et al., 2007), suggesting that
there may be differences in mDA developmental mechanisms
between the chick and mammalian systems. Although these
elegant studies shed important insights into mDA development,c.
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regulates key mDA factors remain largely unknown.
In this study, we identified a Wnt1-Lmx1a autoregulatory loop
during mDA differentiation of ESCs and confirmed that such
a regulatory loop is also functional in vivo during mouse embry-
onic development. We found that this Wnt1-Lmx1a autoregula-
tory loop directly regulates Otx2 gene expression (through the
canonical Wnt signaling pathway) and Nurr1 and Pitx3 gene
expression (through Lmx1a). We also found that Lmx1a has
overlapping function with Lmx1b in regulating downstream
target genes and that they cross-regulate each other during
mDA differentiation. Furthermore, forced expression of key
targets of the Wnt1 pathway (Otx2 and Lmx1a) and a key target
of the SHH pathway (FoxA2) synergistically induced mDA differ-
entiation of ESCs, showing the importance of understanding
mDA developmental mechanisms in optimal differentiation of
ESCs into mDA neurons.
RESULTS
Wnt1 Directly Regulates the Expression of Lmx1a
and Otx2 during mDA Differentiation
FoxA2 is a direct downstream target of the SHH signaling
pathway (Sasaki et al., 1997), but the direct downstream targets
of the Wnt1 signaling pathway during mDA development are still
unclear (Figure 1A). To address this question, J1 ESCs were
differentiated in vitro and infected with empty or Wnt1-express-
ing retrovirus at the NP stage (Figure S1 available online). To
clearly see the effect of transgene expression without masking
their effect by culture conditions, we used suboptimal condition
without anyDA-inducing factors. Cells were further differentiated
and analyzed at day 3 of the neuronal differentiation (ND) stage
(termedND3 in the text). This is the time point of activemDA neu-
rogenesis and differentiation in this stem cell culture bioassay,
thus optimal to analyze the expression of potential mDA regula-
tors/targets. Quantitative real-time PCR (qPCR) analysis re-
vealed that forced Wnt1 expression significantly increased
mRNA levels of Otx2, Pitx3, and to a greater extent Lmx1a (Fig-
ure 1B), but not those of FoxA2, Nurr1, or Msx1. The lack of an
effect on the expression of these genes at this early time point
suggests that they are not the direct targets of Wnt1 signaling,
though they may be regulated by genes further downstream.
Consistent with this mRNA analysis, immunocytochemisty
analysis revealed an increased number of Lmx1a+ cells after
Wnt1 overexpression (Figures 1C and 1D) from 7.05 ± 0.78 to
16.20 ± 1.11 (%Lmx1a+ cells/Hoechst+ cells; p < 0.05). In addi-
tion, Otx2+ or Pitx3+ cell numbers, but not Nurr1+ cell numbers,
were significantly increased after Wnt1 overexpression (Fig-
ure S2).
It was previously shown that SHH treatment could ventralize
chick intermediate midbrain explants, accompanied by induc-
tion of Lmx1a and other ventral midbrain phenotype (Andersson
et al., 2006b). Therefore, we tested whetherWnt1 can still induce
Lmx1a in the presence of the SHH signaling inhibitor cyclop-
amine (Kittappa et al., 2007) and found that Wnt1 induced
Lmx1a independent of SHH signaling (Figure S3A). We next
tested whether acute treatment with SHH or cyclopamine had
an immediate effect on Lmx1a expression. ESC-derived NP cells
were treated with 500 ng/ml SHH or 1 mM cyclopamine for 6 hrCeand analyzed by qPCR. Although these treatments led to corre-
sponding changes in Gli1 mRNA levels, there were no significant
changes in Lmx1amRNA levels (Figure 1E) aswell as TH or Nurr1
mRNA levels (Figure S3B), suggesting that these genes are not
direct targets of the SHH signaling. However, it is still possible
that SHH can indirectly regulate these genes through further
downstream targets.
To address whether Wnt1 directly regulates any of these
potential targets via the canonical Wnt signaling pathway, we
performed chromatin immunoprecipitation (ChIP)-qPCR anal-
ysis. At day 1 of the NP stage, in vitro differentiated ESCs were
transduced with retroviral Wnt1, treated with 15 mM LiCl at
day 3 to stabilize b-catenin, and then fixed for ChIP at day 4.
ChIP was performed either with a control antibody or with b-cat-
enin antibody. qPCR analysis showed significant binding of
b-catenin complex to the well-conserved TCF/LEF binding site
in the Lmx1a promoter, but not to another potential TCF/LEF
site in the third intron of Lmx1a, showing the specificity of b-cat-
enin binding in our assay system (Figure 1F). For the Otx2
promoter, ChIP-qPCR analysis showed that there is direct asso-
ciation of the b-catenin complex to its well-conserved TCF/LEF
sites during mDA differentiation (Figure 1F). We used the
c-myc promoter’s TCF/LEF binding sites as positive control
(Yochum et al., 2007) and observed comparable binding with
the Lmx1a promoter and the Otx2 promoter (Figure 1F). In the
absence of LiCl treatment, the ChIP experiment yielded compa-
rable results (Figure S4), suggesting that Wnt1 expression alone
is sufficient for stabilizing the b-catenin complex in this system.
Furthermore, this binding of b-catenin complex was Wnt1
dependent (Figure S4). For the Pitx3 promoter, the regulation
by Wnt1 appears to be indirect, because we could not find
well-conserved TCF/LEF binding sites on the Pitx3 promoter,
even though there is a possibility of regulation by a long-range
enhancer.
To further test whether these direct downstream targets are
bound by the b-catenin complex in vivo during embryonic devel-
opment, we performed the ChIP analysis by using dissected VM
of E11.5 embryo. This analysis confirmed that the Lmx1a and
Otx2 promoters are physically associated with the b-catenin
complex (Figure 1G), supporting our in vitro data that Lmx1a
and Otx2 are direct targets of the Wnt1 signaling pathway during
mDA development.
Lmx1a Directly Regulates Wnt1 Expression during mDA
Differentiation
Because Lmx1a showed the most robust effect byWnt1 overex-
pression, we attempted to identify Lmx1a’s downstream targets.
J1 ESCs were differentiated in vitro, infected with empty or
Lmx1a-expressing retrovirus at the NP stage, and analyzed at
ND3 after further differentiation. Interestingly, qPCR analysis
showed that Lmx1a dramatically increased expression of
Wnt1, but not that of SHH or Wnt5a (Figure 2A). We also overex-
pressed Lmx1a by using episomal vector and observed similar
results (data not shown). In addition, immunocytochemical
analysis showed that exogenous Lmx1a expression robustly
increased the numbers of Wnt1+ cells (Figures 2B and 2C).
We next tested the possibility that Lmx1a directly regulates the
expression of Wnt1 by ChIP-qPCR analysis. In vitro differenti-
ated J1 cells at the NP stage were transduced with retrovirusll Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Inc. 647
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Wnt1-Lmx1a Pathway in Dopaminergic DifferentiationFigure 1. Wnt1 Directly Regulates Lmx1a and Otx2 through the b-Catenin Complex
(A) Two major signaling molecules involved in mDA differentiation are SHH from notochord and Wnt1 from Isthmus. FoxA2 is shown to be a direct downstream
target of the SHH signaling pathway and then FoxA2 in turn induces VM SHH expression. The direct downstream target of the Wnt1 signaling pathway remains
elusive. FGF8 from the hindbrain side of Isthmus and Wnt1 from the midbrain side of Isthmus cross-regulate each other, shown by black arrow.
(B) qPCR analysis of DA regulator expression on in vitro differentiated cells transduced with empty or Wnt1-expressing retrovirus (ND3; n = 4, p < 0.05, data are
represented as mean ± SEM throughout this study).
(C and D) Immunocytochemistry analysis on the same cells. Scale bar represents 50 mm.
(E) NP-stage cells were treated with 500 ng/ml of SHH or 1 mM Cyclopamine for 6 hr and analyzed by qPCR.
(F) ChIP-qPCR analysis. In vitro differentiated cells were transduced with Wnt1-expressing retrovirus, treated with 15 mM LiCl for 24 hr, and fixed for ChIP at the
NP stage. ChIP fragments were immunoprecipitated with normal rabbit IgG or b-catenin antibody and analyzed by qPCR. The average of three independent ChIP
analyses (n = 3, p < 0.05, data are represented as mean ± SEM) are presented.
(G) E11.5 VMs were dissected as illustrated without LiCl treatment and used for ChIP with b-catenin antibody (n = 3, p < 0.05, data are represented as mean ±
SEM).648 Cell Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Inc.
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(A) qPCRanalysis on in vitro differentiatedESCswith emptyor Lmx1a-express-
ing retrovirus (ND3; n = 4, p < 0.05, data are represented as mean ± SEM).
(B andC) Immunocytochemistry on the samecells. Scale bar represents 50mm.
Inset shows Hoechst staining.
(D) ChIP-qPCR analysis on Wnt1 and Wnt5a promoter region (n = 3, p < 0.05,
data are represented as mean ± SEM). In vitro differentiated ESCs transduced
with retrovirus expressing HA-tagged Lmx1a was fixed for ChIP at ND3. ChIP
fragments were immunoprecipitated either with normal rabbit IgG or HA anti-
body and analyzed by qPCR. Results represent the average of three indepen-
dent ChIP experiments.Ceexpressing HA-tagged Lmx1a and harvested for ChIP at ND3.
Crosslinked chromatin complex was immunoprecipitated with
HA antibody or control IgG and analyzed by qPCR. There was
significant Lmx1a binding to the well-conserved homeodomain
binding site in the Wnt1 promoter, but not to six well-conserved
sites contained in four PCR fragments on the Wnt5a promoter,
demonstrating the specificity of in vivo Lmx1a binding (Fig-
ure 2D). Importantly, these ChIP data are consistent with the
overexpression data that Lmx1a regulates Wnt1, but not
Wnt5a (Figures 2A–2C), further supporting the validity of our
ChIP analysis. We confirmed the binding of Lmx1a to the Wnt1
promoter by an independent method (electrophoretic mobility
shift assay [EMSA]) and observed specific DNA-protein complex
formation that was supershifted by Lmx1a antibody (Figure S5A).
Taken together, our results reveal the presence of a tight autor-
egulatory loop between Wnt1 and Lmx1a during mDA differenti-
ation of ESCs.
Next, we tested whether Lmx1a regulates the expression of
Wnt1 during mouse embryonic midbrain development in vivo,
by using the wild-type (wt) and dreher (dr/dr) mice (Millonig
et al., 2000). In situ hybridization analysis of littermate wt versus
dr/dr embryos showed that Wnt1 expression is compromised by
Lmx1a mutation in developing midbrain (Figures 3A–3D). At
E11.5, this defect was more evident, although Wnt1 expression
was partially spared in the ventral-most part (Figures 3C and
3D). One possible explanation of this residual Wnt1 expression
is the functional compensation by Lmx1b, which is expressed
in the entire mDA domain at E10.5 (Figures 3E and 3G) and in
the ventral-most part at E11.5 (Figures 3F and 3H), which will
be further discussed later. The specificity of the antibodies
against Lmx1a and Lmx1b is shown in Figure S6. To further
test whether there is a direct interaction between Lmx1a and
the Wnt1 promoter during embryonic development, we per-
formed ChIP analysis by using dissected VM of E11.5 embryo
and found that the Wnt1 promoter is physically associated with
Lmx1a in developing VM (Figure 3I), confirming the presence
of the Wnt1-Lmx1a autoregulatory loop in the embryo as well
as during ESC differentiation.
To quantitatively analyze the effect of Lmx1amutation on gene
expression in vivo, we purified E11.5 mesencephalic floor plate
(mFP) cells, which generate mDA neurons (Kittappa et al.,
2007; Ono et al., 2007), from littermates wt and dr/dr embryos.
To purify mFP cells, we did fluorescent activated cell sorting
(FACS; Figure 3L) by using antibody against corin, a cell surface
marker specifically expressed in developing FP cells (Figures 3J
and 3K; Ono et al., 2007). mRNA analysis showed that Lmx1a
mutation caused a significant decrease (approximately 60%) in
expression ofWnt1, but not that ofWnt5a (Figure 3M), consistent
with the result from ESC differentiation (Figure 2A). We observed
mild decrease in Lmx1a, Lmx1b, and Ngn2 mRNA levels in the
dr/dr embryos, consistent with the previous study (Ono et al.,
2007).
Lmx1a Directly Binds the Promoter Element(s)
and Regulates Expression of Nurr1 and Pitx3
In addition to Wnt1 gene regulation by Lmx1a mutation, there
was significant reduction in the expression of Nurr1 and Pitx3
(Figure 3M). In the dr/dr embryo, this downregulation of Nurr1
and Pitx3 could be an indirect effect of defective DA neuronll Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Inc. 649
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Wnt1-Lmx1a Pathway in Dopaminergic DifferentiationFigure 3. Lmx1a Regulates Wnt1 Expression during Embryonic Midbrain Development
(A–D) In situ hybridization analysis of Wnt1 expression. Coronal mesencephalic section of E10.5 (A, B) and E11.5 (C, D) littermate wt or dr/dr embryos. d marks
dorsal mesencephalon and v marks VM.
(E–H) Lmx1b is expressed in the entire ventral midbrain of E10.5 embryos but is restricted to the ventral-most part in E11.5 embryos. Coronal midbrain sections
were stained with Lmx1b or Lmx1a antibody. The white line marks ventricle. Scale bar represents 50 mm.
(I) E11.5 VMswere dissected as illustrated and used for ChIP with Lmx1a antibody. Binding of Lmx1a to theWnt1 promoter was assayed by qPCR (n = 3, p < 0.05,
data are represented as mean ± SEM).
(J and K) Corin antibody used for FACS purification marks the mDA domain, as shown in E11.5 VM of littermate wt or dr/dr embryo. Scale bar represents 50 mm.
(L) FACS purification of mDA domain cells of littermate wt and dr/dr after staining with corin antibody and Alexa-647-conjugated secondary antibody. The corin+
population is marked.
(M) qPCR analysis of purified mDA domain cells on the expression of regulators of mDA neuronal development. The result is the average from three independent
FACS purifications (n = 3, p < 0.05, data are represented as mean ± SEM).differentiation. Alternatively, it may be caused by direct regula-
tion of Lmx1a. To address these possibilities, we tested whether
Lmx1a directly regulates the expression of Pitx3 and Nurr1
during ESC in vitro differentiation. Retroviral Lmx1a expression
increased the expression of Pitx3, Nurr1, and Lmx1b, whereas650 Cell Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Incit failed to significantly affect the expression of Otx2, FoxA2, or
En1 at ND3 (Figure 4A). We also observed significant increase
inMsx1 and Ngn2mRNA levels, consistent with a previous study
(Andersson et al., 2006b). We also repeated this experiment by
using an episomal Lmx1a expression system and obtained.
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showed that exogenous Lmx1a expression increased the
number of Nurr1+ cells (Figures 4B and 4C; from 2.07% ± 0.38%
to 3.88% ± 0.46% Nurr1+ cells/Hoechst+ cells) and Pitx3+ cells
(Figures 4E and 4F; from 0.58% ± 0.40% to 3.50% ± 0.33%
Pitx3+ cells/Hoechst+ cells) as well as Lmx1b+ cells (Figures
S7A and S7B). Interestingly, many Pitx3+ cells and Nurr1+ cells
were not yet positive for TH at ND3 (Figures 4C and 4F), suggest-
ing that the increase in Pitx3 and Nurr1 gene expression is
a direct effect, but not the byproduct of increased mDA neurons.
At a later time point (ND7), the majority of Pitx3+ cells became
TH+, suggesting that Lmx1a precociously induced Pitx3 expres-
sion in immature DA neurons (Figures S7C–S7F). In addition,
Lmx1a expression significantly increased the percent of TH+
cells/b-tubulin+ cells from 0.87% ± 0.21% to 2.98% ± 0.84%
without supplementing the culture with SHH, unlike the previous
report where the effect of Lmx1a on DA induction was strictly
dependent upon addition of SHH to the culture (Andersson
et al., 2006b). Endogenous SHH expression at the NP stage
may explain such difference.
To further address whether Lmx1a directly regulates gene
expression of themDA regulators Nurr1 and Pitx3, we performed
ChIP analysis. We found Lmx1a significantly bound to Nurr1A
and Nurr1C PCR fragments, but not the Nurr1B fragment
(Figure 4D), and confirmed the specific binding of Lmx1a by
supershift EMSA (Figure S5B). For the Pitx3 promoter, we
observed significant Lmx1a binding to Pitx3A, but not Pitx3B
PCR fragment (Figure 4G), and also confirmed it by supershift
EMSA (Figure S5C). We also performed ChIP to test whether
Ngn2 is directly regulated by Lmx1a, but observed no significant
binding (Figure S8B).
To further confirm the regulation of Nurr1 and Pitx3 by Lmx1a
during embryonic midbrain development, we performed immu-
nohistochemistry and stereological analysis on littermate wt
and dr/dr embryos. We counted the number of Nurr1+ and
Pitx3+ cells in the entire mDA domain in every 6th coronal VM
section, by using the StreoInvestigator image capture equipment
and software. We found significant decreases in Nurr1+ and
Pitx3+ cell numbers in dr/dr embryos compared to littermate
wt embryos (Figures 4H–4M), whereas there was no significant
difference in the FoxA2+ or Otx2+ cell numbers between wt
and dr/dr embryos (Figures S9A and S9B). Taken together, our
results strongly suggest that Lmx1a directly regulates Nurr1
and Pitx3, but not FoxA2 or Otx2, both in mDA differentiation
of ESCs and in embryonic midbrain development.
Lmx1a and Lmx1b Have Overlapping Functions
in Regulating mDA Regulators
Compared to the robust induction of mDA differentiation in ESCs
by Lmx1a, drehermice displayed onlymild dysregulation ofmDA
development. This could be explained either by lack of functional
significance of Lmx1a during embryonicmDAdevelopment or by
the presence of another gene with redundant function. For the
latter possibility, Lmx1b is one such candidate, because (1) it
is expressed in the same domain as Lmx1a duringmDAdevelop-
ment and (2) it is highly related to Lmx1a with 61% overall amino
acid identity (Hobert and Westphal, 2000). Thus, to explore
whether Lmx1b and Lmx1a share some redundant functions in
mDA differentiation, we compared the effect of Lmx1a andCeLmx1b’s overexpression during in vitro differentiation of ESCs.
J1 ESCs were differentiated in vitro, infected with Lmx1a- or
Lmx1b-expressing retrovirus at the NP stage, and analyzed at
ND3. In line with Wnt1’s residual expression pattern in dr/dr
embryos (Figures 3A–3H), both Lmx1a and Lmx1b upregulated
Wnt1 expression (Figure 5A). SHH expression was unaffected
by either gene, whereas both Pitx3 and Nurr1 expression were
upregulated by Lmx1a or Lmx1b (Figure 5A), showing the redun-
dant function of Lmx1a and Lmx1b in target gene regulation.
Interestingly, Lmx1b expression mildly but significantly upregu-
lated Lmx1a expression (Figure 5A). ChIP analysis showed that
Lmx1b binds to the Lmx1a promoter and also Lmx1a binds to
the Lmx1b promoter, indicating cross-regulation between these
two genes (Figure S8B). In addition, we also examined whether
there is any self-regulation of Lmx1a or Lmx1b. qPCR analysis
with endogenous message-specific primers revealed that
Lmx1a regulates itself, but Lmx1b does not (Figure S8A). Consis-
tent with this, we observed that Lmx1a but not Lmx1b specifi-
cally binds to the well conserved binding site within its own
promoter (Figure S8B).
Observed cross-regulation between Lmx1a and Lmx1b raised
the possibility that Lmx1b regulates target genes indirectly
through Lmx1a. Thus, to test whether Lmx1b can directly regu-
late target genes, we did ChIP-qPCR analysis after transduction
with retrovirus expressing HA-tagged Lmx1b. We found that
Lmx1b significantly bound to the promoters of Wnt1, Nurr1,
and Pitx3 (Figure 5B), though milder than Lmx1a. We also tested
the binding of Lmx1a or Lmx1b to the Msx1 promoter and found
that they both bind to the well conserved homeodomain binding
sites residing at3.5 kb upstreamof theMsx1 gene (Figure S10).
To further study the redundant function between Lmx1a and
Lmx1b, we attempted to knock down these genes by using
gene-specific siRNA approach. ESC-derived NP cells were
treated with SHH and FGF8 for 4 days to induce/proliferate mDA
NPs, and then transfected with control siRNA, Lmx1a siRNA,
Lmx1bsiRNA,orbothLmx1a/1bsiRNAsviaNucleofector (Amaxa)
and analyzed after 30 hr. Transfection of each siRNA treatment
significantly reduced the mRNA level of Lmx1a or Lmx1b (Figures
5C and 5E–5H). Transfection of single siRNA did not have signifi-
cant effect on Wnt1 or Nurr1 gene expression. This insignificant
effect is in contrast with the robust induction effect observed in
overexpression experiment (Figure 5A). This can be explained
by incomplete knockdown by siRNA and/or nonphysiological
overexpression effect causedby retroviral transduction.However,
when both genes were knocked down, there was significant
decrease in the target gene expression (Figures 5C and 5I–5L;
Figure S11), suggesting that Lmx1a and Lmx1b compensate
each other’s function in regulatingmDA regulator genes. Because
Pitx3+ cells were not yet detectable at this NP stage, we repeated
the gene knockdown experiment at ND-stage cells. ESC-derived
cells were treated with SHH and FGF8 for 4 days, differentiated
in N3 media for 2 days, transfected with siRNA, and analyzed
by qPCR analysis 30 hr after transfection. siRNA treatment to
each gene significantly reduced the mRNA level of Lmx1a or
Lmx1b (Figure 5D). Only when both Lmx1a and Lmx1b genes
were knocked down was there significant decrease in Nurr1 and
Pitx3 gene expression (Figures 5D, 5M, and 5N). Furthermore,
knock down of both genes also downregulated TH mRNA level
and TH+ cell numbers (Figures 5D, 5O, and 5P).ll Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Inc. 651
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(A) qPCR analysis on in vitro differentiated ESCs with empty or Lmx1a-expressing retrovirus (ND3; n = 4, p < 0.05, data are represented as mean ± SEM).
(B and C) Immunocytochemistry on the same cells. Scale bar represents 50 mm.
(D) ChIP-qPCR analysis on Nurr1 promoter region (n = 3, p < 0.05, data are represented as mean ± SEM), performed as described above.
(E and F) Immunocytochemistry on the same cells.
(G) ChIP-qPCR analysis on Pitx3 promoter region (n = 3, p < 0.05, data are represented as mean ± SEM), performed as described above.
(H and I) Immunohistochemistry analysis of VM in E12.5 littermates’ wt and dr/dr embryos via Nurr1 and TH antibody. M denotesmedial VM. Scale bar represents
50 mm.652 Cell Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Inc.
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Wnt1-Lmx1a Pathway in Dopaminergic DifferentiationWnt1-Lmx1 Autoregulatory Loop Induces mDA
Differentiation Synergistically with the SHH Signaling
Pathway
The most salient finding of this study is the tight autoregulatory
loop between Wnt1 and Lmx1a during mDA differentiation of
ESCs as well as during embryonic midbrain development. This
autoregulatory loop, in turn, directly regulates Otx2 expression,
through the canonical Wnt signaling pathway, and Nurr1 and
Pitx3 expression, through Lmx1a. This finding about the Wnt1
pathway together with prior knowledge about the SHH-FoxA2
pathway in mDA differentiation prompted us to hypothesize
that activation of both signaling pathways by exogenous expres-
sion of direct downstream targets of these pathways (i.e., Otx2,
Lmx1a, and FoxA2) may synergistically induce mDA differentia-
tion. To test such a hypothesis, we transduced ESC-derived NPs
with FoxA2-, Lmx1a-, or Otx2-expressing retroviruses, either
alone or together. Indeed, when all three key mediators (Lmx1a,
Otx2, and FoxA2) were overexpressed, we observed a robust
synergistic induction of the mDA marker genes, TH, Pitx3, and
Nurr1 (Figure 6A), as examined by qPCR analysis. Immunocyto-
chemical analysis also showed significant increase in mDA
neurons as shown by increase in the number of cells expressing
both TH and Pitx3 (Figures 6B–6E). However, there was no
significant change in b-tubulin+ neuronal cell numbers or
GFAP+ astrocyte cell numbers (Figures 6F and 6G). Further anal-
ysis showed that TH+ neurons generated by activation of both
signaling pathways represent mature DA neuronal phenotype
assessed by coexpression of DAT and DDC, but not by empty
vector transduction (Figures 6H–6O). In the three factor-trans-
duced cells, the majority of TH+ neurons also coexpressed
Lmx1b and Nurr1, confirming their mDA phenotype, but not in
the empty-vector-transduced cells (Figures 6P–6W). Three
factor-transduced cells contained both A9-like (Aldh1a1+) and
A10-like (Calbindin+) mDA neurons (Figures S12A and S12B).
In addition, other non-DA neurons such as serotonergic (5HT+),
cholinergic (ChAT+), or GABAergic (GABA+) neurons were simi-
larly observed after in vitro differentiation of both empty vector-
transduced and three factor-transduced cells (Figures S12C–
S12E; data not shown). Cell counting analysis showed that there
was a significant increase in % TH+ cells/b-tubulin+ cells by
three-factor transduction from 4.85% ± 0.24% to 26.30% ±
0.49% (from 2.35% ± 0.11% to 13.22% ± 0.57% TH+/Hoechst+
cells).
DISCUSSION
Midbrain dopaminergic (mDA) neurons critically control volun-
tary movement, emotion, and reward through specific neuronal
circuits (Bjorklund and Lindvall, 1984), and their selective degen-
eration and/or dysregulation is associated with major neurolog-
ical and psychiatric disorders. Especially, selective loss of
mDA neurons in the substantia nigra is associated with PD
(Lang and Lozano, 1998). Successful cell replacement therapyCefor PD requires generation of optimal cell sources. There has
been extensive effort to generate mDA neurons from stem cells
(Chung et al., 2002; Kawasaki et al., 2000; Kim et al., 2002), but
optimal differentiation of stem cells to authentic mDA neurons
requires further understanding of the molecular mechanisms
underlying mDA neuronal development. Toward this goal,
numerous laboratories investigated mDA neuron development,
resulting in identification of important signaling molecules (e.g.,
SHH and Wnt1) and key transcription factors (e.g., FoxA2,
Lmx1a, Lmx1b, Msx1, Ngn2, Nurr1, and Pitx3) (reviewed in
Ang, 2006; Smidt and Burbach, 2007). However, molecular inter-
actions/networks between these extrinsic factors and intrinsic
transcription factors are not well understood.
In this study, by analyzing molecular networks involving Wnt1
during mDA differentiation of ESCs, we showed that Wnt1
directly regulates Lmx1a, a key intrinsic factor for mDA differen-
tiation, eliciting functional cascades that lead to mDA differenti-
ation. The early function of Wnt1 based on its expression in the
isthmus (<E9.5) is well established (McMahon et al., 1992), but
how Wnt1 functions in mDA differentiation through its ventral
midbrain expression (E9.5–E12.5) has not been fully understood.
The Wnt1-regulated molecular network revealed in this study
explains the functional role of Wnt1 in mDA phenotype specifica-
tion (Castelo-Branco et al., 2004; Prakash et al., 2006) apart from
its well-established role in NP proliferation (Megason andMcMa-
hon, 2002). Furthermore, we identified the extrinsic signaling
molecule Wnt1 as a major target of Lmx1a during mDA differen-
tiation, forming an autoregulatory loop between Wnt1 and
Lmx1a. Our study further demonstrates that Lmx1a directly
regulates two critical regulators of mDA neuron differentiation,
the Nurr1 and Pitx3 genes as well as Wnt1 and that Wnt1 directly
regulates Otx2 as well as Lmx1a through the canonical Wnt
signaling pathway during mDA differentiation (Figure 7). This
Otx2 regulation byWnt1 is consistent with previous observations
shown by ectopic expression of Wnt1 (Prakash et al., 2006) and
conditional knock out (cKO) of b-catenin (Joksimovic et al., 2009)
during mouse embryonic development. It is also worthwhile to
note that cKO of Otx2 resulted in reduction of Wnt1 expression
in midbrain neurons (Prakash et al., 2006), but this mechanism
may be indirect, considering the role of Otx2 as a transcriptional
repressor. For Lmx1a regulation by the b-catenin complex, two
recent studies showed conflicting results; one reported that
SHH-cre;b-catenin cKO shows significant decrease in Lmx1a
expression (Joksimovic et al., 2009), whereas the other reported
that SHH-cre;b-catenin cKO shows only mild changes (Tang
et al., 2009). Such a controversy raised the need for more direct
in vitro analysis ofWnt1-Lmx1a regulation. Our in vivo and in vitro
analyses described in this study show that the b-catenin
complex indeed directly associates with the Lmx1a promoter
and regulates its expression.
Our new finding that Pitx3 and Nurr1 are the direct down-
stream targets of the Wnt1-Lmx1a autoregulatory loop links
a key signaling pathway of mDA differentiation to the major(J) Cell counting analysis of Nurr1+ cells in ventral midbrain of E12.5 littermates’ wt and dr/dr embryos (n = 4, p < 0.05, data are represented as mean ± SEM). Cell
numbers were counted from every 6th sections via the StereoInvestigator image capture equipment and software. The estimated total cell numbers based on
counting every 6th section are shown.
(K and L) Immunohistochemistry analysis of ventral midbrain in E12.5 littermates wt and dr/dr embryos via Pitx3 antibody.
(M) Cell counting analysis of Pitx3+ cell numbers as described above (n = 4, p < 0.05, data are represented as mean ± SEM).ll Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Inc. 653
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Wnt1-Lmx1a Pathway in Dopaminergic DifferentiationFigure 5. Lma1a and Lmx1b Have Redundant Functions in Midbrain Dopaminergic Differentiation
(A) qPCR analysis on in vitro differentiated cells transduced with empty, Lmx1a-, or Lmx1b-expressing retrovirus at ND3 (n = 4, p < 0.05, data are represented as
mean ± SEM). O.E. denotes overexpression of Lmx1a (20.6 ± 8.2).
(B) ChIP-qPCR analysis of Lmx1b (n = 3, p < 0.05, data are represented as mean ± SEM). In vitro differentiated ESCs transduced with retrovirus expressing HA-
tagged Lmx1bwere fixed for ChIP at ND3. ChIP fragments were immunoprecipitated either with normal rabbit IgG or HA antibody and analyzed by qPCR. Binding
of Lmx1b to the Lmx1a target sites in the Wnt1, Nurr1, or Pitx3 promoters were tested with the same primer sets.
(C) qPCR analysis of siRNA-treated NP cells. ESC-derived NP cells were treated with SHH and FGF8 for 4 days for induction/proliferation of mDA NPs and then
transfected with control siRNA, Lmx1a siRNA, Lmx1b siRNA, or Lmx1a/1b siRNAs, and analyzed 30 hr after transfection (n = 4, p < 0.05, data are represented as
mean ± SEM).654 Cell Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Inc.
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Wnt1-Lmx1a Pathway in Dopaminergic DifferentiationFigure 6. The Wnt1 Signaling Pathway Induces mDA Differentiation of ESCs Synergistically with the SHH Pathway
(A) qPCR analysis on in vitro differentiated cells transduced with empty, FoxA2-, Lmx1a-, or Otx2-expressing retrovirus at ND6 (n = 4, p < 0.05, data are repre-
sented as mean ± SEM). FLO designates cells transduced with all three viruses that express FoxA2, Lmx1a, or Otx2.
(B and C) Cotransduction of three factors (FLO) leads to a significant increase in Pitx3+ TH+ mDA neurons compared to empty virus-transduced cells.
(D–G) Cell transduction with three factors does not significantly alter the proportion of neurons (Tuj1+) or astrocytes (GFAP+).
(H–O) Three factor transduction increases the cells with mature DA phenotype, shown by coexpression of DAT and DDC with TH.
(P–W) Three factor transduction increases cells with mDA phenotype, shown by coexpression of Lmx1b and Nurr1 with TH. Immunocytochemistry on in vitro
differentiated ESCs at stage ND6. Inset shows Hoechst staining. Scale bar represents 50 mm.molecular regulators of terminal differentiation/survival of mDA
neurons. A recent study with FoxA2 KO mice revealed that
FoxA2 regulates Nurr1 expression in developing midbrain (Ferri
et al., 2007), and in the present study we observed that Lmx1a
directly binds to the Nurr1 promoter in vivo and activates Nurr1Ceexpression. Thus, it seems that regulation of Nurr1 is one of
the converging points of the SHH-FoxA2 pathway and the
Wnt1-Lmx1a pathway. However, Lmx1a did not affect SHH or
FoxA2 expression, showing the independent nature of these
two pathways. In addition, our data show that Lmx1a is a link(D) qPCR analysis of siRNA-treated ND cells. ESC-derived NP cells were treated with SHH and FGF8 for 4 days for induction/proliferation of mDA NPs, further
differentiated until day 2 of ND stage, transfected with control siRNA, Lmx1a siRNA, Lmx1b siRNA, or Lmx1a/1b siRNAs, and analyzed 30 hr after transfection
(n = 4, p < 0.05, data are represented as mean ± SEM).
(E–L) Immunocytochemistry on NP cells treated with control siRNA or Lmx1a/1b siRNAs 1 day after transfection. Scale bar represents 50 mm.
(M–P) Immunocytochemistry on ND cells treated with control siRNA or Lmx1a/1b siRNAs 1 day after transfection. Scale bar represents 50 mm.ll Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Inc. 655
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Wnt1-Lmx1a Pathway in Dopaminergic DifferentiationFigure 7. Two Major Signaling Pathways during
Midbrain Dopaminergic Neuronal Differentiation
The emerging genetic network of the Wnt1 signaling pathway
reveals the interaction between the Wnt1 and SHH pathways
at three major steps of mDA development: (1) ventralization
and inhibition of alternate fates, (2) promotion of neurogenesis,
and (3) DA phenotype specification and survival. Arrow indi-
cates positive regulation and -j indicates negative regulation.
Black arrows indicate the regulation previously shown. Green
and purple arrows indicate the regulations observed in this
study. Overlapping function of Lmx1b is indicated by purple
arrows. Dotted lines represent regulations that are not shown
to be direct yet. Solid lines represent regulation that has been
shown to be direct. Please refer to the Discussion section for
details and related references.between a major signaling molecule Wnt1 and an important
mDA-specific transcription factor, Pitx3. Interestingly, Prakash
et al. (2006) observed that in Wnt1 KO mice, the few surviving
TH+ neurons never express Pitx3. Furthermore, Smidt et al.
(2000) observed that in Lmx1b KO mice the few observed TH+
neurons also failed to express Pitx3. Taken together, these
previous studies corroborate our results and suggest the exis-
tence of a cascade linking Wnt1, Lmx1a/1b, and Pitx3 for mDA
differentiation.
Lmx1a was first identified for its roof plate phenotype (Millonig
et al., 2000), but until recently its role in ventral midbrain develop-
ment remained unknown. This is likely due to its mild ventral
phenotype caused by compensation by Lmx1b, as shown here.
This is different from the chick system where Lmx1b cannot
compensate for the loss of Lmx1a in midbrain DA development
and where disruption of Lmx1a leads to complete absence of
midbrain DA neurons even in the presence of Lmx1b (Andersson
et al., 2006b). In contrast, our data strongly suggest that, in the
mouse system, Lmx1a and Lmx1b cooperatively regulate mDA
neuron development by sharing redundant functions. First, our
gene expression analyses of mDA domains and developing
corin+ mFP cells showed that mDA phenotype is only mildly
affected in Lmx1a mutant dr/dr embryo. Notably, the defect of
target gene (Wnt1) expression was modest in the ventral-most
part where Lmx1b is still expressed, suggesting its compen-
sating function. Second, our siRNA-based single and double
knock down experiments of Lmx1a and Lmx1b in in vitro
differentiated ESCs showed that knocking down a single gene
has no or marginal effect on target gene expression, whereas
knocking down both genes significantly affected target gene
expression. Third, our extensive ChIP analyses indicate that
both Lmx1a and Lmx1b directly bind to the promoters of target
genes during mDA differentiation of ESCs, again supporting
their redundant functions during mDA differentiation. In line
with our results, Dr. Siew-Lan Ang’s laboratory observed that
whereas Lmx1adreher/dreher or ShhCre/+, Lmx1bflox/flox embryos
show partial or no reduction in the number of mDA neurons,
respectively, there was a much more severe loss of mDA
neurons in Lmx1adreher/dreher;ShhCre/+, Lmx1bflox/flox double
mutant embryos at E12.5 (personal communication). The severe
mDA phenotype of Lmx1b KO mice (Smidt et al., 2000)
compared to the no phenotype in ShhCre/+, Lmx1bflox/flox mice
could be caused by its early role in isthmus formation (Guo656 Cell Stem Cell 5, 646–658, December 4, 2009 ª2009 Elsevier Inet al., 2007; Matsunaga et al., 2002) and/or by differences in
genetic backgrounds. Despite the observed overlapping func-
tion of Lmx1a and Lmx1b in regulating downstream targets,
Lmx1b is not regulated by Wnt1 (Matsunaga et al., 2002). In
line with this, we could not find well-conserved TCF/LEF binding
sites in the 50 kb Lmx1b promoter.
In summary, as opposed to the previously known SHH-FoxA2
pathway, this study identified an important complementary
pathway for mDA development, the Wnt1-Lmx1a autoregulatory
loop, duringmDAdifferentiation of ESCs aswell as duringmouse
embryonic midbrain development. Notably, this Wnt1-Lmx1a
pathway appears to be formed independent of the SHH-FoxA2
pathway, although they functionally interact with each other
during mDA development. In support of this notion, our data
show that overexpression of SHH or its blocking by cyclopamine
did not affect Lmx1a expression. In addition, induction of Lmx1a
gene expression by Wnt1 during in vitro differentiation of ESCs
was not affected by cyclopamine. Based on our work along
with previous studies, we propose that these twomajor signaling
pathways, once formed, functionally interact with each other at
three major steps of mDA development (Figure 7). First, the
SHH-FoxA2 pathway induces the ventral phenotype, but also
induces the alternate ventral phenotype characterized by the
markers Nkx2.2 and Nkx6.1 (Ferri et al., 2007; Pabst et al.,
2000; Vokes et al., 2007), which is inhibited by the Lmx1a-
Wnt1 pathway through Otx2 (Prakash et al., 2006) and Msx1
(Andersson et al., 2006b). FoxA2 also inhibits the Nkx2.2 pheno-
type, which is induced by SHH (Ferri et al., 2007). Furthermore,
Joksimovic et al. (2009) recently demonstrated the importance
of more direct inhibition of SHH expression by Wnt1 at early
time point (<E10.5) of mDA differentiation, adding another layer
of regulation to the functional crosstalk between SHH and
Wnt1 pathway for mDA differentiation. Second, another major
step of mDA development is the conversion of nonneuronal FP
cells to NPs, in which proneural genes such as Ngn2 could
play an important role (Andersson et al., 2006a; Kele et al.,
2006). Two signaling pathways collaborate on this step, as
FoxA2, Otx2, and Msx1 activate Ngn2 expression (Andersson
et al., 2006b; Ferri et al., 2007; Vernay et al., 2005), thus
promoting neurogenesis. Third, these two pathways also collab-
orate on the expression of functional DA genes such as TH
and DAT. The SHH-FoxA2 pathway, directly or through Nurr1,
plays an important role in expression of these genes, and thec.
Cell Stem Cell
Wnt1-Lmx1a Pathway in Dopaminergic DifferentiationWnt1-Lmx1a pathway, through Pitx3 and Nurr1, regulates these
genes’ expression (Figure 7; Ang, 2006; Smidt and Burbach,
2007). These intimate functional interactions between these
two pathways predict that activation of key mediators of both
signaling pathways may facilitate ESC differentiation to mDA
neurons by efficiently providing the proper cellular environment
for each other. Indeed, activation of both pathways by exoge-
nous expression of three key mediators resulted in synergistic
induction of mDA differentiation, compared to the induction of
a single pathway. These studies demonstrate the usefulness
of ESC differentiation to investigate the molecular network of
mDA differentiation and also in turn show that knowledge gained
from such mechanistic studies can facilitate the generation of
cell sources for cell replacement therapy for PD.
EXPERIMENTAL PROCEDURES
ESC Culture and In Vitro Differentiation
ESCs were maintained and differentiated as described previously (Chung
et al., 2002); for more details, see Supplemental Data.
For transgenic expression studies, we intentionally used suboptimal condi-
tions to clearly see the effect of transgene expression without masking its
effect by stimulating its upstream events by culture conditions. So we did
not add any signaling molecules such as SHH, FGF8, or ascorbic acids; any
growth factors such as GDNF or BDNF; or any feeders such as MS5 nor
PA6 (Andersson et al., 2006b; Kawasaki et al., 2000; Kim et al., 2002).
For siRNA transfection, NP-stage cells were treated with 50 ng/ml FGF8 and
100 ng/ml SHH for 4 days to induce/proliferate mDA NPs, followed by trans-
fection with siRNA with the Nucleofector (Amaxa, Walkersville, MD) mouse
stem cell kit with the program A-033 according to the manufacturer’s instruc-
tion. Per transfection, 5 3 106 NP cells were treated with 480 pmol of siRNA,
diluted in 10 ml of N3bFGF media (or N3 media for ND-stage transfection),
and plated in PLO/FN-coatedmultiwell plate, resulting in a final siRNA concen-
tration of 48 nM. For ND-stage transfection, cells were further differentiated in
N3 media for 2 days before transfection. Multiple Stealth siRNAs were
purchased from Invitrogen (Carlsbad, CA) and screened for gene silencing effi-
ciency by cotransfection with Lmx1a or Lmx1b-expressing plasmids, and only
siRNAs showing efficient gene silencing (>95%) were used for the experi-
ments. The sequences of the siRNAs are as follows: the Lmx1a sense strand
GAGGAGAGCAUUCAAGGCCUCGUUU; the Lmx1a antisense strand AAAC
GAGGCCUUGAAUGCUCUCCUC; the Lmx1b sense strand GGAACGACUC
CAUCUUCCACGAUAU; and the Lmx1b antisense strand AUAUCGUGGAA
GAUGGAGUCGUUCC. Thirty hours after transfection, cells were fixed for
immunocytochemistry or harvested for RNA preparation.
Cell Counting and Statistical Analysis
Cells were counted from blind-coded samples with an integrated Axioskop 2
microscope (Carl Zeiss, Thornwood, NY) and the StereoInvestigator image
capture equipment and software (Microbright Field, Williston, VT). For statis-
tical analysis, we used the Statview software and performed analysis of vari-
ance (ANOVA) with an alpha level of 0.05 to determine possible statistical
differences between group means. When significant differences were found,
post hoc analysis was performed with Fisher’s PLSD (alpha = 0.05).
ChIP-qPCR Analysis
ChIP-qPCR analysis was done as described previously (Yochum et al., 2007),
and for details see Supplemental Data.
Mouse
Heterozygous drehermice were purchased from the Jackson Laboratory (Bar
Harbor, ME). B6C3Fe a/a-Lmx1adr-J/Jmouse harbors a pointmutation, which
makes Lmx1a protein nonfunctional (Millonig et al., 2000). For details on
embryo analysis, see Supplemental Data. All animal studies were performed
according to National Institutes of Health guidelines and were approved by
the Institutional Animal Care and Use Committees at McLean Hospital.CeFACS Purification
FACS purification was done as described previously (Pruszak et al., 2007), and
for details, see Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and 12
figures and can be found with this article online at http://www.cell.com/
cell-stem-cell/supplemental/S1934-5909(09)00511-6.
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